Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Free Report) in a report published on Wednesday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Stock Performance NYSEAMERICAN:AMPE opened at $0.21 on Wednesday. The stock has a fifty day moving average price of $0.25 and a 200-day moving […]

Related Keywords

Montreal ,Quebec ,Canada ,Colorado ,United States ,Blackrock ,Nova Scotia ,Englewood , ,Institutional Trading Of Ampio Pharmaceuticals ,Ampio Pharmaceuticals Inc ,Ampio Pharmaceuticals Company Profile ,Millennium Management ,Ampio Pharmaceuticals Stock Performance ,Blackrock Inc ,News Ratings For Ampio Pharmaceuticals Daily ,Ampio Pharmaceuticals ,Vanguard Group Inc ,Free Report ,Get Free Report ,Street Corp ,Montreal Can ,Ampio Pharmaceuticals Daily ,Nyseamerican Ampe ,Ampe ,Medical ,03209t10 ,Initiated Coverage ,Stocknews Com ,